Molar pregnancy

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Treatments and drugs

By Mayo Clinic staff

A molar pregnancy can't continue as a normal viable pregnancy. To prevent complications, the molar tissue must be removed.

To treat a molar pregnancy, your health care provider will remove the molar tissue from your uterus with a procedure called dilation and curettage (D and C). A D and C is usually done as an outpatient procedure in a hospital.

During the procedure, you'll receive local or general anesthesia and lie on your back with your legs in stirrups. Your health care provider will insert a speculum into your vagina, as in a pelvic exam, to see your cervix. He or she will then dilate your cervix and remove uterine tissue with a vacuum device. A D and C usually takes about 15 to 30 minutes.

If the molar tissue is extensive and there's no desire for future pregnancies, the uterus may be removed (hysterectomy).

After the molar tissue is removed, your health care provider will again measure your HCG level. If you continue to have HCG in your blood, you may need additional treatment. Once treatment for the molar pregnancy is complete, your health care provider will continue to monitor your HCG levels for six months to one year to make sure there's no remaining molar tissue. Because pregnancy makes it difficult to monitor HCG levels, your health care provider may recommend waiting up to one year before trying to become pregnant again.

References
  1. Early pregnancy loss: Miscarriage and molar pregnancy. American College of Obstetricians and Gynecologists. http://www.acog.org/publications/patient_education/bp090.cfm. Accessed Aug. 14, 2009.
  2. Ectopic and molar pregnancy. March of Dimes. http://www.marchofdimes.com/professionals/14332_1189.asp. Accessed Aug. 14, 2009.
  3. Copeland LJ, et al. Malignant diseases in pregnancy. In: Gabbe SG, et al. Obstetrics: Normal and Problem Pregnancies. 5th ed. Philadelphia, Pa.: Elsevier Churchill Livingstone; 2007:1.
  4. Garner EIO. Gestational trophoblastic disease: Management of hydatidiform mole. http://www.uptodate.com/home/index.html. Accessed Aug. 17, 2009.
  5. Berek JS. Gestational trophoblastic disease: Pathology. http://www.uptodate.com/home/index.html. Accessed Aug. 17, 2009.
  6. Chang JW, et al. Gestational trophoblastic disease: Epidemiology, clinical manifestations and diagnosis. http://www.uptodate.com/home/index.html. Accessed Aug. 17, 2009.
  7. Garner EIO. Malignant gestational trophoblastic disease: Staging and treatment. http://www.uptodate.com/home/index.html. Accessed Aug. 17, 2009.
  8. Kavanagh JJ, et al. Comprehensive gynecology. Gestational trophoblastic disease: Hydatidiform mole, nonmetastatic and metastatic gestational trophoblastic tumor — Diagnosis and management. In: Katz VL, et al. Comprehensive Gynecology. 5th ed. Philadelphia, Pa: Mosby Elsevier; 2007:1.
  9. Dilation and curettage. American College of Obstetricians and Gynecologists. http://www.acog.org/publications/patient_education/bp062.cfm. Accessed Aug. 18, 2009.
  10. Al-Hussaini TK, et al. Recurrent pregnancy loss due to familial and non-familial habitual molar pregnancy. International Journal of Gynecology and Obstetrics. 2003;83:179.
  11. Harms RW (expert opinion). Mayo Clinic, Rochester, Minn. Sept. 16, 2009.

DS01155

Nov. 6, 2009

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger